Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.
about
Remuscularization of the failing heart.Engineered Heart Repair.Efficient Killing of Murine Pluripotent Stem Cells by Natural Killer (NK) Cells Requires Activation by Cytokines and Partly Depends on the Activating NK Receptor NKG2D.Immunological Properties of Murine Parthenogenetic Stem Cells and Their Differentiation ProductsIGF1 and NRG1 Enhance Proliferation, Metabolic Maturity, and the Force-Frequency Response in hESC-Derived Engineered Cardiac Tissues.Functional correction of dystrophin actin binding domain mutations by genome editing.Cardiac Progenitor Cells and the Interplay with Their MicroenvironmentPassive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.Ajmaline blocks INa and IKr without eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters.Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues.Large Cardiac-Muscle Patches Engineered from Human Induced-Pluripotent Stem-Cell-Derived Cardiac Cells Improve Recovery from Myocardial Infarction in Swine.Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application.Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest.Inspiration from heart development: Biomimetic development of functional human cardiac organoids.Myocardial Tissue Engineering for Regenerative Applications.Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing.Construction of a vascularized hydrogel for cardiac tissue formation in a porcine model.A context-specific cardiac β-catenin and GATA4 interaction influences TCF7L2 occupancy and remodels chromatin driving disease progression in the adult heart.State-of-the-Art in Tissue-Engineered Heart RepairScalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small Molecules.One Stride Forward: Maturation and Scalable Production of Engineered Human Myocardium.Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.Traction force microscopy of engineered cardiac tissues.Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues.3D and 4D Bioprinting of the Myocardium: Current Approaches, Challenges, and Future Prospects.Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue.Elastic serum-albumin based hydrogels: mechanism of formation and application in cardiac tissue engineeringGenetic and Tissue Engineering Approaches to Modeling the Mechanics of Human Heart Failure for Drug DiscoveryModels of Ischemia-Reperfusion Injury
P2860
Q39179497-AE13083C-55A5-4FEA-80D9-6373CE2B15CDQ39404465-A6403389-1CDE-42D7-B587-A04542A4A564Q40054588-E5B7739F-A0DF-4F7C-BFB2-CBC0CB971B56Q41242617-3F4DEFD4-27C8-4D4C-9052-5B2AA73F8918Q41690530-5FC57B96-2823-46E0-877C-304D7BF9B814Q42162721-A95FAEFA-FCC4-4171-A3D2-6CBEC852E366Q42718220-37CC067E-8A55-4355-BF46-AF92D84333DFQ46240809-565A6768-3811-403A-B8FE-855802DBBA4DQ47144807-70627B28-2425-4B3E-9F59-87BE940E7D8FQ47160787-0DA50AC7-C88C-421E-97FD-E60A0BF29768Q47256386-FBA51748-0C13-4A13-84BB-7ACE773B6B2AQ47270959-15BF905D-2209-47D2-A454-B59A580E1C60Q47668884-A611CDC6-56F7-45BC-846D-F4BBC60BFE2EQ47819879-EFB38BA7-B53D-4EE6-A1C5-A422EAE0E678Q47871478-487F8103-FB71-4DDB-9EC0-A18BEB56F14EQ48041681-2E7011E1-FEEF-4F6D-8F09-83A57FF2C621Q48365875-1905D35B-E25F-4543-BEA2-0643805D9965Q48773384-3EB50368-5FFE-4056-BE77-26F8B556D4E0Q48774892-85570A44-1011-49A3-8566-8B9FB898684FQ50085979-1C63C0B3-8A56-4D43-8F7A-DC60E9E05E64Q50883568-AD280127-1337-4669-9AE5-C4C5217E0A4BQ51417867-35C9E9D6-4DAA-4C63-816F-E555578B6273Q52625621-76EF209C-393E-48D5-8D23-FCF5965656C2Q52657121-0873BA1B-2F9E-48C2-A228-8C9B1AF5720FQ52722649-47BF1C13-867C-46C5-8EB0-DB28D55AEB93Q54975606-46E49EDB-3582-4837-9C9E-75C5624BD55BQ55399061-D15464F4-8502-4721-BAD3-59DFE0901336Q57071280-FB135660-B77E-4ED3-9240-62B7103EE05EQ57072496-B3A2AEEE-6FC9-4333-B45E-AE97CD4711AEQ58561894-349060B0-2032-4F83-9340-41486121B921
P2860
Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Defined Engineered Human Myoca ...... t Failure Modeling and Repair.
@en
Defined Engineered Human Myoca ...... t Failure Modeling and Repair.
@nl
type
label
Defined Engineered Human Myoca ...... t Failure Modeling and Repair.
@en
Defined Engineered Human Myoca ...... t Failure Modeling and Repair.
@nl
prefLabel
Defined Engineered Human Myoca ...... t Failure Modeling and Repair.
@en
Defined Engineered Human Myoca ...... t Failure Modeling and Repair.
@nl
P2093
P2860
P50
P1433
P1476
Defined Engineered Human Myoca ...... rt Failure Modeling and Repair
@en
P2093
Andreas Unger
Benjamin Neel
Elif Levent
Erich Wettwer
Farah Raad
Gerd Hasenfuss
Johannes Riegler
Joseph C Wu
Joseph D Gold
Karl Toischer
P2860
P304
P356
10.1161/CIRCULATIONAHA.116.024145
P407
P577
2017-02-06T00:00:00Z